nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP11A1—Cholecalciferol—psoriasis	0.149	0.206	CbGbCtD
Terbinafine—CYP11A1—Dexamethasone—psoriasis	0.0643	0.0893	CbGbCtD
Terbinafine—CYP19A1—Betamethasone—psoriasis	0.0515	0.0715	CbGbCtD
Terbinafine—CYP2C8—Tazarotene—psoriasis	0.0506	0.0703	CbGbCtD
Terbinafine—CYP1A2—Clobetasol propionate—psoriasis	0.0481	0.0668	CbGbCtD
Terbinafine—CYP19A1—Dexamethasone—psoriasis	0.0299	0.0416	CbGbCtD
Terbinafine—CYP1A2—Methoxsalen—psoriasis	0.0253	0.0351	CbGbCtD
Terbinafine—CYP2D6—Hydroxyurea—psoriasis	0.0227	0.0316	CbGbCtD
Terbinafine—CYP2C8—Cholecalciferol—psoriasis	0.0216	0.03	CbGbCtD
Terbinafine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0187	0.026	CbGbCtD
Terbinafine—CYP2C19—Cholecalciferol—psoriasis	0.0181	0.0252	CbGbCtD
Terbinafine—CYP3A4—Calcitriol—psoriasis	0.017	0.0236	CbGbCtD
Terbinafine—CYP2C9—Cholecalciferol—psoriasis	0.0151	0.0209	CbGbCtD
Terbinafine—CYP2C8—Hydrocortisone—psoriasis	0.015	0.0209	CbGbCtD
Terbinafine—CYP2C8—Cyclosporine—psoriasis	0.0142	0.0197	CbGbCtD
Terbinafine—CYP2D6—Cholecalciferol—psoriasis	0.0138	0.0192	CbGbCtD
Terbinafine—CYP3A4—Methoxsalen—psoriasis	0.0132	0.0184	CbGbCtD
Terbinafine—CYP2C19—Prednisone—psoriasis	0.0126	0.0175	CbGbCtD
Terbinafine—CYP2C19—Cyclosporine—psoriasis	0.0119	0.0166	CbGbCtD
Terbinafine—CYP2C9—Cyclosporine—psoriasis	0.0099	0.0138	CbGbCtD
Terbinafine—CYP2C8—Dexamethasone—psoriasis	0.00935	0.013	CbGbCtD
Terbinafine—CYP2D6—Cyclosporine—psoriasis	0.00906	0.0126	CbGbCtD
Terbinafine—CYP3A4—Cholecalciferol—psoriasis	0.00876	0.0122	CbGbCtD
Terbinafine—CYP2C19—Dexamethasone—psoriasis	0.00784	0.0109	CbGbCtD
Terbinafine—CYP3A4—Triamcinolone—psoriasis	0.0076	0.0106	CbGbCtD
Terbinafine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0076	0.0106	CbGbCtD
Terbinafine—CYP2C9—Dexamethasone—psoriasis	0.00652	0.00906	CbGbCtD
Terbinafine—CYP3A4—Betamethasone—psoriasis	0.00652	0.00906	CbGbCtD
Terbinafine—CYP3A4—Prednisolone—psoriasis	0.00643	0.00894	CbGbCtD
Terbinafine—CYP3A4—Hydrocortisone—psoriasis	0.0061	0.00847	CbGbCtD
Terbinafine—CYP3A4—Prednisone—psoriasis	0.00607	0.00844	CbGbCtD
Terbinafine—CYP2D6—Dexamethasone—psoriasis	0.00596	0.00829	CbGbCtD
Terbinafine—CYP3A4—Cyclosporine—psoriasis	0.00576	0.008	CbGbCtD
Terbinafine—CYP3A4—Dexamethasone—psoriasis	0.00379	0.00527	CbGbCtD
Terbinafine—SQLE—Activation of gene expression by SREBF (SREBP)—CARM1—psoriasis	0.00194	0.0442	CbGpPWpGaD
Terbinafine—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00174	0.0396	CbGpPWpGaD
Terbinafine—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00155	0.0353	CbGpPWpGaD
Terbinafine—SQLE—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—psoriasis	0.00155	0.0353	CbGpPWpGaD
Terbinafine—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00143	0.0325	CbGpPWpGaD
Terbinafine—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00142	0.0322	CbGpPWpGaD
Terbinafine—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.00133	0.0303	CbGpPWpGaD
Terbinafine—CYP11A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00124	0.0283	CbGpPWpGaD
Terbinafine—CYP11A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00123	0.0279	CbGpPWpGaD
Terbinafine—SQLE—Statin Pathway—APOE—psoriasis	0.0012	0.0273	CbGpPWpGaD
Terbinafine—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.00108	0.0245	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—IVL—psoriasis	0.00104	0.0236	CbGpPWpGaD
Terbinafine—CYP11A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.00101	0.0229	CbGpPWpGaD
Terbinafine—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000964	0.0219	CbGpPWpGaD
Terbinafine—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000886	0.0201	CbGpPWpGaD
Terbinafine—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000879	0.02	CbGpPWpGaD
Terbinafine—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000824	0.0187	CbGpPWpGaD
Terbinafine—CYP19A1—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000814	0.0185	CbGpPWpGaD
Terbinafine—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000751	0.0171	CbGpPWpGaD
Terbinafine—CYP19A1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000668	0.0152	CbGpPWpGaD
Terbinafine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000579	0.0132	CbGpPWpGaD
Terbinafine—PTGS1—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000563	0.0128	CbGpPWpGaD
Terbinafine—CYP11A1—Biological oxidations—CYP2S1—psoriasis	0.000536	0.0122	CbGpPWpGaD
Terbinafine—CYP11A1—Metapathway biotransformation—CYP2S1—psoriasis	0.000529	0.012	CbGpPWpGaD
Terbinafine—SQLE—SREBP signalling—PPARG—psoriasis	0.000523	0.0119	CbGpPWpGaD
Terbinafine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000448	0.0102	CbGpPWpGaD
Terbinafine—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000442	0.01	CbGpPWpGaD
Terbinafine—PTGS1—Overview of nanoparticle effects—CRP—psoriasis	0.000415	0.00943	CbGpPWpGaD
Terbinafine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.0004	0.00909	CbGpPWpGaD
Terbinafine—CYP19A1—Ovarian Infertility Genes—VDR—psoriasis	0.000398	0.00903	CbGpPWpGaD
Terbinafine—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000395	0.00897	CbGpPWpGaD
Terbinafine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000368	0.00836	CbGpPWpGaD
Terbinafine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000365	0.00829	CbGpPWpGaD
Terbinafine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000363	0.00826	CbGpPWpGaD
Terbinafine—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000363	0.00825	CbGpPWpGaD
Terbinafine—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00036	0.00818	CbGpPWpGaD
Terbinafine—CYP19A1—Biological oxidations—CYP2S1—psoriasis	0.000355	0.00807	CbGpPWpGaD
Terbinafine—CYP19A1—Metapathway biotransformation—CYP2S1—psoriasis	0.00035	0.00795	CbGpPWpGaD
Terbinafine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000324	0.00737	CbGpPWpGaD
Terbinafine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000312	0.00708	CbGpPWpGaD
Terbinafine—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000308	0.00699	CbGpPWpGaD
Terbinafine—CYP19A1—Tryptophan metabolism—CAT—psoriasis	0.000306	0.00696	CbGpPWpGaD
Terbinafine—PTGS1—Biological oxidations—CYP2S1—psoriasis	0.000299	0.00679	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000299	0.00678	CbGpPWpGaD
Terbinafine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000298	0.00678	CbGpPWpGaD
Terbinafine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000296	0.00672	CbGpPWpGaD
Terbinafine—PTGS1—Overview of nanoparticle effects—CXCL8—psoriasis	0.00027	0.00614	CbGpPWpGaD
Terbinafine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000253	0.00574	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—NDUFA5—psoriasis	0.000249	0.00566	CbGpPWpGaD
Terbinafine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000241	0.00547	CbGpPWpGaD
Terbinafine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000237	0.00539	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000232	0.00528	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—CYP2S1—psoriasis	0.000212	0.00481	CbGpPWpGaD
Terbinafine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000195	0.00443	CbGpPWpGaD
Terbinafine—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.000193	0.00439	CbGpPWpGaD
Terbinafine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000192	0.00437	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—NFKBIA—psoriasis	0.000192	0.00437	CbGpPWpGaD
Terbinafine—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.00019	0.00432	CbGpPWpGaD
Terbinafine—PTGS1—Overview of nanoparticle effects—TNF—psoriasis	0.000188	0.00427	CbGpPWpGaD
Terbinafine—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000172	0.00391	CbGpPWpGaD
Terbinafine—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.00017	0.00386	CbGpPWpGaD
Terbinafine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000168	0.00381	CbGpPWpGaD
Terbinafine—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000167	0.0038	CbGpPWpGaD
Terbinafine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000158	0.0036	CbGpPWpGaD
Terbinafine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.000157	0.00357	CbGpPWpGaD
Terbinafine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000156	0.00355	CbGpPWpGaD
Terbinafine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000155	0.00352	CbGpPWpGaD
Terbinafine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000154	0.00349	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—CAT—psoriasis	0.000153	0.00349	CbGpPWpGaD
Terbinafine—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000153	0.00347	CbGpPWpGaD
Terbinafine—PTGS1—Overview of nanoparticle effects—IL6—psoriasis	0.000152	0.00345	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.00015	0.0034	CbGpPWpGaD
Terbinafine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000143	0.00325	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—CXCL8—psoriasis	0.000137	0.00312	CbGpPWpGaD
Terbinafine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000134	0.00305	CbGpPWpGaD
Terbinafine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000132	0.00301	CbGpPWpGaD
Terbinafine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000132	0.003	CbGpPWpGaD
Terbinafine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.00013	0.00296	CbGpPWpGaD
Terbinafine—CYP11A1—Corticotropin-releasing hormone—NFKB1—psoriasis	0.000123	0.00279	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—CRP—psoriasis	0.000122	0.00277	CbGpPWpGaD
Terbinafine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000117	0.00265	CbGpPWpGaD
Terbinafine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	0.000116	0.00263	CbGpPWpGaD
Terbinafine—PTGS1—Selenium Micronutrient Network—ICAM1—psoriasis	0.000112	0.00254	CbGpPWpGaD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—APOE—psoriasis	0.000111	0.00252	CbGpPWpGaD
Terbinafine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000111	0.00251	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—NDUFA5—psoriasis	0.000108	0.00245	CbGpPWpGaD
Terbinafine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	0.000104	0.00235	CbGpPWpGaD
Terbinafine—SQLE—Metabolism—CARM1—psoriasis	0.000103	0.00235	CbGpPWpGaD
Terbinafine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	0.000102	0.00232	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000101	0.00228	CbGpPWpGaD
Terbinafine—Angioedema—Betamethasone—psoriasis	0.0001	0.000424	CcSEcCtD
Terbinafine—Angioedema—Dexamethasone—psoriasis	0.0001	0.000424	CcSEcCtD
Terbinafine—Decreased appetite—Mycophenolate mofetil—psoriasis	0.0001	0.000423	CcSEcCtD
Terbinafine—Anorexia—Hydrocortisone—psoriasis	0.0001	0.000423	CcSEcCtD
Terbinafine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.98e-05	0.00227	CbGpPWpGaD
Terbinafine—Diarrhoea—Mycophenolic acid—psoriasis	9.98e-05	0.000422	CcSEcCtD
Terbinafine—Angiopathy—Prednisone—psoriasis	9.97e-05	0.000422	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	9.94e-05	0.000421	CcSEcCtD
Terbinafine—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	9.93e-05	0.00226	CbGpPWpGaD
Terbinafine—Immune system disorder—Prednisone—psoriasis	9.92e-05	0.00042	CcSEcCtD
Terbinafine—Malaise—Betamethasone—psoriasis	9.9e-05	0.000419	CcSEcCtD
Terbinafine—Malaise—Dexamethasone—psoriasis	9.9e-05	0.000419	CcSEcCtD
Terbinafine—Anaphylactic shock—Triamcinolone—psoriasis	9.88e-05	0.000418	CcSEcCtD
Terbinafine—Vertigo—Betamethasone—psoriasis	9.86e-05	0.000417	CcSEcCtD
Terbinafine—Vertigo—Dexamethasone—psoriasis	9.86e-05	0.000417	CcSEcCtD
Terbinafine—Pain—Mycophenolate mofetil—psoriasis	9.85e-05	0.000417	CcSEcCtD
Terbinafine—Infection—Triamcinolone—psoriasis	9.81e-05	0.000415	CcSEcCtD
Terbinafine—Feeling abnormal—Cyclosporine—psoriasis	9.73e-05	0.000411	CcSEcCtD
Terbinafine—Alopecia—Prednisone—psoriasis	9.71e-05	0.000411	CcSEcCtD
Terbinafine—SQLE—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.67e-05	0.0022	CbGpPWpGaD
Terbinafine—Hepatobiliary disease—Methotrexate—psoriasis	9.67e-05	0.000409	CcSEcCtD
Terbinafine—Gastrointestinal pain—Cyclosporine—psoriasis	9.65e-05	0.000408	CcSEcCtD
Terbinafine—Dizziness—Mycophenolic acid—psoriasis	9.65e-05	0.000408	CcSEcCtD
Terbinafine—Paraesthesia—Prednisolone—psoriasis	9.64e-05	0.000408	CcSEcCtD
Terbinafine—Mental disorder—Prednisone—psoriasis	9.62e-05	0.000407	CcSEcCtD
Terbinafine—Erythema—Prednisone—psoriasis	9.56e-05	0.000405	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	9.56e-05	0.000404	CcSEcCtD
Terbinafine—Agranulocytosis—Methotrexate—psoriasis	9.54e-05	0.000404	CcSEcCtD
Terbinafine—Feeling abnormal—Mycophenolate mofetil—psoriasis	9.49e-05	0.000401	CcSEcCtD
Terbinafine—Paraesthesia—Hydrocortisone—psoriasis	9.42e-05	0.000398	CcSEcCtD
Terbinafine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	9.41e-05	0.000398	CcSEcCtD
Terbinafine—Urticaria—Cyclosporine—psoriasis	9.38e-05	0.000397	CcSEcCtD
Terbinafine—Myalgia—Betamethasone—psoriasis	9.35e-05	0.000396	CcSEcCtD
Terbinafine—Myalgia—Dexamethasone—psoriasis	9.35e-05	0.000396	CcSEcCtD
Terbinafine—Abdominal pain—Cyclosporine—psoriasis	9.33e-05	0.000395	CcSEcCtD
Terbinafine—Body temperature increased—Cyclosporine—psoriasis	9.33e-05	0.000395	CcSEcCtD
Terbinafine—Anxiety—Betamethasone—psoriasis	9.32e-05	0.000394	CcSEcCtD
Terbinafine—Anxiety—Dexamethasone—psoriasis	9.32e-05	0.000394	CcSEcCtD
Terbinafine—Vomiting—Mycophenolic acid—psoriasis	9.28e-05	0.000392	CcSEcCtD
Terbinafine—Discomfort—Dexamethasone—psoriasis	9.24e-05	0.000391	CcSEcCtD
Terbinafine—Discomfort—Betamethasone—psoriasis	9.24e-05	0.000391	CcSEcCtD
Terbinafine—Dyspepsia—Hydrocortisone—psoriasis	9.23e-05	0.000391	CcSEcCtD
Terbinafine—Rash—Mycophenolic acid—psoriasis	9.2e-05	0.000389	CcSEcCtD
Terbinafine—Dermatitis—Mycophenolic acid—psoriasis	9.19e-05	0.000389	CcSEcCtD
Terbinafine—Pain—Prednisolone—psoriasis	9.18e-05	0.000389	CcSEcCtD
Terbinafine—Hepatitis—Methotrexate—psoriasis	9.18e-05	0.000388	CcSEcCtD
Terbinafine—CYP11A1—Metabolism—CYP2S1—psoriasis	9.17e-05	0.00208	CbGpPWpGaD
Terbinafine—Urticaria—Mycophenolate mofetil—psoriasis	9.15e-05	0.000387	CcSEcCtD
Terbinafine—Headache—Mycophenolic acid—psoriasis	9.14e-05	0.000387	CcSEcCtD
Terbinafine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	9.14e-05	0.00208	CbGpPWpGaD
Terbinafine—Decreased appetite—Hydrocortisone—psoriasis	9.12e-05	0.000386	CcSEcCtD
Terbinafine—Abdominal pain—Mycophenolate mofetil—psoriasis	9.1e-05	0.000385	CcSEcCtD
Terbinafine—Body temperature increased—Mycophenolate mofetil—psoriasis	9.1e-05	0.000385	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Hydrocortisone—psoriasis	9.06e-05	0.000383	CcSEcCtD
Terbinafine—Fatigue—Hydrocortisone—psoriasis	9.04e-05	0.000383	CcSEcCtD
Terbinafine—Vision blurred—Prednisone—psoriasis	9.01e-05	0.000381	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Triamcinolone—psoriasis	9e-05	0.000381	CcSEcCtD
Terbinafine—Pain—Hydrocortisone—psoriasis	8.97e-05	0.000379	CcSEcCtD
Terbinafine—Anaphylactic shock—Betamethasone—psoriasis	8.96e-05	0.000379	CcSEcCtD
Terbinafine—Anaphylactic shock—Dexamethasone—psoriasis	8.96e-05	0.000379	CcSEcCtD
Terbinafine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	8.94e-05	0.00203	CbGpPWpGaD
Terbinafine—Infection—Betamethasone—psoriasis	8.9e-05	0.000377	CcSEcCtD
Terbinafine—Infection—Dexamethasone—psoriasis	8.9e-05	0.000377	CcSEcCtD
Terbinafine—Ill-defined disorder—Prednisone—psoriasis	8.87e-05	0.000375	CcSEcCtD
Terbinafine—Paraesthesia—Triamcinolone—psoriasis	8.87e-05	0.000375	CcSEcCtD
Terbinafine—Feeling abnormal—Prednisolone—psoriasis	8.85e-05	0.000374	CcSEcCtD
Terbinafine—Visual impairment—Methotrexate—psoriasis	8.85e-05	0.000374	CcSEcCtD
Terbinafine—Anaemia—Prednisone—psoriasis	8.84e-05	0.000374	CcSEcCtD
Terbinafine—Nervous system disorder—Betamethasone—psoriasis	8.79e-05	0.000372	CcSEcCtD
Terbinafine—Nervous system disorder—Dexamethasone—psoriasis	8.79e-05	0.000372	CcSEcCtD
Terbinafine—Thrombocytopenia—Dexamethasone—psoriasis	8.77e-05	0.000371	CcSEcCtD
Terbinafine—Thrombocytopenia—Betamethasone—psoriasis	8.77e-05	0.000371	CcSEcCtD
Terbinafine—Angioedema—Prednisone—psoriasis	8.74e-05	0.00037	CcSEcCtD
Terbinafine—Hypersensitivity—Cyclosporine—psoriasis	8.7e-05	0.000368	CcSEcCtD
Terbinafine—Dyspepsia—Triamcinolone—psoriasis	8.69e-05	0.000368	CcSEcCtD
Terbinafine—Erythema multiforme—Methotrexate—psoriasis	8.68e-05	0.000367	CcSEcCtD
Terbinafine—Nausea—Mycophenolic acid—psoriasis	8.67e-05	0.000367	CcSEcCtD
Terbinafine—Feeling abnormal—Hydrocortisone—psoriasis	8.64e-05	0.000366	CcSEcCtD
Terbinafine—Malaise—Prednisone—psoriasis	8.62e-05	0.000365	CcSEcCtD
Terbinafine—Vertigo—Prednisone—psoriasis	8.59e-05	0.000363	CcSEcCtD
Terbinafine—Eye disorder—Methotrexate—psoriasis	8.58e-05	0.000363	CcSEcCtD
Terbinafine—Gastrointestinal pain—Hydrocortisone—psoriasis	8.58e-05	0.000363	CcSEcCtD
Terbinafine—Tinnitus—Methotrexate—psoriasis	8.56e-05	0.000362	CcSEcCtD
Terbinafine—Anorexia—Betamethasone—psoriasis	8.54e-05	0.000361	CcSEcCtD
Terbinafine—Anorexia—Dexamethasone—psoriasis	8.54e-05	0.000361	CcSEcCtD
Terbinafine—Urticaria—Prednisolone—psoriasis	8.53e-05	0.000361	CcSEcCtD
Terbinafine—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	8.52e-05	0.00194	CbGpPWpGaD
Terbinafine—Fatigue—Triamcinolone—psoriasis	8.51e-05	0.00036	CcSEcCtD
Terbinafine—Hypersensitivity—Mycophenolate mofetil—psoriasis	8.48e-05	0.000359	CcSEcCtD
Terbinafine—Asthenia—Cyclosporine—psoriasis	8.47e-05	0.000358	CcSEcCtD
Terbinafine—Pain—Triamcinolone—psoriasis	8.45e-05	0.000357	CcSEcCtD
Terbinafine—Pruritus—Cyclosporine—psoriasis	8.35e-05	0.000353	CcSEcCtD
Terbinafine—Urticaria—Hydrocortisone—psoriasis	8.33e-05	0.000353	CcSEcCtD
Terbinafine—Angiopathy—Methotrexate—psoriasis	8.33e-05	0.000352	CcSEcCtD
Terbinafine—Immune system disorder—Methotrexate—psoriasis	8.29e-05	0.000351	CcSEcCtD
Terbinafine—Body temperature increased—Hydrocortisone—psoriasis	8.29e-05	0.000351	CcSEcCtD
Terbinafine—Abdominal pain—Hydrocortisone—psoriasis	8.29e-05	0.000351	CcSEcCtD
Terbinafine—Asthenia—Mycophenolate mofetil—psoriasis	8.26e-05	0.000349	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Dexamethasone—psoriasis	8.16e-05	0.000345	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Betamethasone—psoriasis	8.16e-05	0.000345	CcSEcCtD
Terbinafine—Pruritus—Mycophenolate mofetil—psoriasis	8.15e-05	0.000345	CcSEcCtD
Terbinafine—Arthralgia—Prednisone—psoriasis	8.14e-05	0.000344	CcSEcCtD
Terbinafine—Myalgia—Prednisone—psoriasis	8.14e-05	0.000344	CcSEcCtD
Terbinafine—Feeling abnormal—Triamcinolone—psoriasis	8.14e-05	0.000344	CcSEcCtD
Terbinafine—Anxiety—Prednisone—psoriasis	8.11e-05	0.000343	CcSEcCtD
Terbinafine—Alopecia—Methotrexate—psoriasis	8.11e-05	0.000343	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	8.08e-05	0.000342	CcSEcCtD
Terbinafine—Diarrhoea—Cyclosporine—psoriasis	8.07e-05	0.000342	CcSEcCtD
Terbinafine—Paraesthesia—Betamethasone—psoriasis	8.05e-05	0.00034	CcSEcCtD
Terbinafine—Paraesthesia—Dexamethasone—psoriasis	8.05e-05	0.00034	CcSEcCtD
Terbinafine—Discomfort—Prednisone—psoriasis	8.04e-05	0.00034	CcSEcCtD
Terbinafine—Mental disorder—Methotrexate—psoriasis	8.04e-05	0.00034	CcSEcCtD
Terbinafine—Erythema—Methotrexate—psoriasis	7.99e-05	0.000338	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisolone—psoriasis	7.91e-05	0.000335	CcSEcCtD
Terbinafine—Dyspepsia—Dexamethasone—psoriasis	7.89e-05	0.000334	CcSEcCtD
Terbinafine—Dyspepsia—Betamethasone—psoriasis	7.89e-05	0.000334	CcSEcCtD
Terbinafine—Diarrhoea—Mycophenolate mofetil—psoriasis	7.88e-05	0.000333	CcSEcCtD
Terbinafine—Urticaria—Triamcinolone—psoriasis	7.85e-05	0.000332	CcSEcCtD
Terbinafine—Dysgeusia—Methotrexate—psoriasis	7.83e-05	0.000331	CcSEcCtD
Terbinafine—Body temperature increased—Triamcinolone—psoriasis	7.81e-05	0.00033	CcSEcCtD
Terbinafine—Dizziness—Cyclosporine—psoriasis	7.8e-05	0.00033	CcSEcCtD
Terbinafine—Anaphylactic shock—Prednisone—psoriasis	7.8e-05	0.00033	CcSEcCtD
Terbinafine—Decreased appetite—Betamethasone—psoriasis	7.79e-05	0.00033	CcSEcCtD
Terbinafine—Decreased appetite—Dexamethasone—psoriasis	7.79e-05	0.00033	CcSEcCtD
Terbinafine—Infection—Prednisone—psoriasis	7.75e-05	0.000328	CcSEcCtD
Terbinafine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	7.74e-05	0.00176	CbGpPWpGaD
Terbinafine—Gastrointestinal disorder—Dexamethasone—psoriasis	7.74e-05	0.000327	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Betamethasone—psoriasis	7.74e-05	0.000327	CcSEcCtD
Terbinafine—Hypersensitivity—Hydrocortisone—psoriasis	7.73e-05	0.000327	CcSEcCtD
Terbinafine—Fatigue—Betamethasone—psoriasis	7.73e-05	0.000327	CcSEcCtD
Terbinafine—Fatigue—Dexamethasone—psoriasis	7.73e-05	0.000327	CcSEcCtD
Terbinafine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	7.7e-05	0.00175	CbGpPWpGaD
Terbinafine—Pain—Dexamethasone—psoriasis	7.66e-05	0.000324	CcSEcCtD
Terbinafine—Pain—Betamethasone—psoriasis	7.66e-05	0.000324	CcSEcCtD
Terbinafine—Nervous system disorder—Prednisone—psoriasis	7.65e-05	0.000324	CcSEcCtD
Terbinafine—Dizziness—Mycophenolate mofetil—psoriasis	7.61e-05	0.000322	CcSEcCtD
Terbinafine—Skin disorder—Prednisone—psoriasis	7.58e-05	0.000321	CcSEcCtD
Terbinafine—Vision blurred—Methotrexate—psoriasis	7.53e-05	0.000319	CcSEcCtD
Terbinafine—Asthenia—Hydrocortisone—psoriasis	7.53e-05	0.000318	CcSEcCtD
Terbinafine—Vomiting—Cyclosporine—psoriasis	7.5e-05	0.000317	CcSEcCtD
Terbinafine—Rash—Cyclosporine—psoriasis	7.44e-05	0.000315	CcSEcCtD
Terbinafine—Anorexia—Prednisone—psoriasis	7.44e-05	0.000315	CcSEcCtD
Terbinafine—Dermatitis—Cyclosporine—psoriasis	7.43e-05	0.000315	CcSEcCtD
Terbinafine—Pruritus—Hydrocortisone—psoriasis	7.42e-05	0.000314	CcSEcCtD
Terbinafine—Ill-defined disorder—Methotrexate—psoriasis	7.41e-05	0.000314	CcSEcCtD
Terbinafine—Headache—Cyclosporine—psoriasis	7.39e-05	0.000313	CcSEcCtD
Terbinafine—Anaemia—Methotrexate—psoriasis	7.39e-05	0.000313	CcSEcCtD
Terbinafine—Feeling abnormal—Betamethasone—psoriasis	7.38e-05	0.000312	CcSEcCtD
Terbinafine—Feeling abnormal—Dexamethasone—psoriasis	7.38e-05	0.000312	CcSEcCtD
Terbinafine—Gastrointestinal pain—Betamethasone—psoriasis	7.33e-05	0.00031	CcSEcCtD
Terbinafine—Gastrointestinal pain—Dexamethasone—psoriasis	7.33e-05	0.00031	CcSEcCtD
Terbinafine—Vomiting—Mycophenolate mofetil—psoriasis	7.32e-05	0.00031	CcSEcCtD
Terbinafine—Hypersensitivity—Triamcinolone—psoriasis	7.28e-05	0.000308	CcSEcCtD
Terbinafine—Rash—Mycophenolate mofetil—psoriasis	7.26e-05	0.000307	CcSEcCtD
Terbinafine—Dermatitis—Mycophenolate mofetil—psoriasis	7.25e-05	0.000307	CcSEcCtD
Terbinafine—Headache—Mycophenolate mofetil—psoriasis	7.21e-05	0.000305	CcSEcCtD
Terbinafine—Malaise—Methotrexate—psoriasis	7.21e-05	0.000305	CcSEcCtD
Terbinafine—Vertigo—Methotrexate—psoriasis	7.18e-05	0.000304	CcSEcCtD
Terbinafine—Diarrhoea—Hydrocortisone—psoriasis	7.18e-05	0.000304	CcSEcCtD
Terbinafine—CYP19A1—Metabolism—NDUFA5—psoriasis	7.14e-05	0.00162	CbGpPWpGaD
Terbinafine—Urticaria—Dexamethasone—psoriasis	7.12e-05	0.000301	CcSEcCtD
Terbinafine—Urticaria—Betamethasone—psoriasis	7.12e-05	0.000301	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Prednisone—psoriasis	7.11e-05	0.000301	CcSEcCtD
Terbinafine—Dizziness—Prednisolone—psoriasis	7.1e-05	0.0003	CcSEcCtD
Terbinafine—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	7.09e-05	0.00161	CbGpPWpGaD
Terbinafine—Asthenia—Triamcinolone—psoriasis	7.09e-05	0.0003	CcSEcCtD
Terbinafine—Body temperature increased—Dexamethasone—psoriasis	7.08e-05	0.0003	CcSEcCtD
Terbinafine—Abdominal pain—Dexamethasone—psoriasis	7.08e-05	0.0003	CcSEcCtD
Terbinafine—Abdominal pain—Betamethasone—psoriasis	7.08e-05	0.0003	CcSEcCtD
Terbinafine—Body temperature increased—Betamethasone—psoriasis	7.08e-05	0.0003	CcSEcCtD
Terbinafine—Nausea—Cyclosporine—psoriasis	7.01e-05	0.000297	CcSEcCtD
Terbinafine—Paraesthesia—Prednisone—psoriasis	7.01e-05	0.000296	CcSEcCtD
Terbinafine—Pruritus—Triamcinolone—psoriasis	6.99e-05	0.000296	CcSEcCtD
Terbinafine—Cough—Methotrexate—psoriasis	6.97e-05	0.000295	CcSEcCtD
Terbinafine—Dizziness—Hydrocortisone—psoriasis	6.94e-05	0.000293	CcSEcCtD
Terbinafine—Dyspepsia—Prednisone—psoriasis	6.87e-05	0.000291	CcSEcCtD
Terbinafine—Nausea—Mycophenolate mofetil—psoriasis	6.84e-05	0.000289	CcSEcCtD
Terbinafine—Arthralgia—Methotrexate—psoriasis	6.8e-05	0.000288	CcSEcCtD
Terbinafine—Chest pain—Methotrexate—psoriasis	6.8e-05	0.000288	CcSEcCtD
Terbinafine—Myalgia—Methotrexate—psoriasis	6.8e-05	0.000288	CcSEcCtD
Terbinafine—Decreased appetite—Prednisone—psoriasis	6.78e-05	0.000287	CcSEcCtD
Terbinafine—Rash—Prednisolone—psoriasis	6.77e-05	0.000286	CcSEcCtD
Terbinafine—Dermatitis—Prednisolone—psoriasis	6.77e-05	0.000286	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	6.76e-05	0.000286	CcSEcCtD
Terbinafine—Fatigue—Prednisone—psoriasis	6.73e-05	0.000285	CcSEcCtD
Terbinafine—Headache—Prednisolone—psoriasis	6.73e-05	0.000285	CcSEcCtD
Terbinafine—Discomfort—Methotrexate—psoriasis	6.72e-05	0.000284	CcSEcCtD
Terbinafine—Vomiting—Hydrocortisone—psoriasis	6.67e-05	0.000282	CcSEcCtD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.66e-05	0.00151	CbGpPWpGaD
Terbinafine—Rash—Hydrocortisone—psoriasis	6.61e-05	0.00028	CcSEcCtD
Terbinafine—Dermatitis—Hydrocortisone—psoriasis	6.61e-05	0.00028	CcSEcCtD
Terbinafine—Confusional state—Methotrexate—psoriasis	6.58e-05	0.000278	CcSEcCtD
Terbinafine—Headache—Hydrocortisone—psoriasis	6.57e-05	0.000278	CcSEcCtD
Terbinafine—Dizziness—Triamcinolone—psoriasis	6.53e-05	0.000276	CcSEcCtD
Terbinafine—Anaphylactic shock—Methotrexate—psoriasis	6.52e-05	0.000276	CcSEcCtD
Terbinafine—Infection—Methotrexate—psoriasis	6.48e-05	0.000274	CcSEcCtD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	6.43e-05	0.00146	CbGpPWpGaD
Terbinafine—Feeling abnormal—Prednisone—psoriasis	6.43e-05	0.000272	CcSEcCtD
Terbinafine—Asthenia—Betamethasone—psoriasis	6.43e-05	0.000272	CcSEcCtD
Terbinafine—Asthenia—Dexamethasone—psoriasis	6.43e-05	0.000272	CcSEcCtD
Terbinafine—Nervous system disorder—Methotrexate—psoriasis	6.4e-05	0.000271	CcSEcCtD
Terbinafine—Thrombocytopenia—Methotrexate—psoriasis	6.39e-05	0.00027	CcSEcCtD
Terbinafine—Gastrointestinal pain—Prednisone—psoriasis	6.38e-05	0.00027	CcSEcCtD
Terbinafine—Nausea—Prednisolone—psoriasis	6.38e-05	0.00027	CcSEcCtD
Terbinafine—SQLE—Metabolism—CAT—psoriasis	6.36e-05	0.00145	CbGpPWpGaD
Terbinafine—Pruritus—Betamethasone—psoriasis	6.34e-05	0.000268	CcSEcCtD
Terbinafine—Pruritus—Dexamethasone—psoriasis	6.34e-05	0.000268	CcSEcCtD
Terbinafine—Skin disorder—Methotrexate—psoriasis	6.33e-05	0.000268	CcSEcCtD
Terbinafine—Vomiting—Triamcinolone—psoriasis	6.28e-05	0.000266	CcSEcCtD
Terbinafine—Nausea—Hydrocortisone—psoriasis	6.23e-05	0.000264	CcSEcCtD
Terbinafine—Rash—Triamcinolone—psoriasis	6.23e-05	0.000263	CcSEcCtD
Terbinafine—Dermatitis—Triamcinolone—psoriasis	6.22e-05	0.000263	CcSEcCtD
Terbinafine—Anorexia—Methotrexate—psoriasis	6.22e-05	0.000263	CcSEcCtD
Terbinafine—Urticaria—Prednisone—psoriasis	6.2e-05	0.000262	CcSEcCtD
Terbinafine—Headache—Triamcinolone—psoriasis	6.19e-05	0.000262	CcSEcCtD
Terbinafine—Abdominal pain—Prednisone—psoriasis	6.17e-05	0.000261	CcSEcCtD
Terbinafine—Body temperature increased—Prednisone—psoriasis	6.17e-05	0.000261	CcSEcCtD
Terbinafine—Diarrhoea—Betamethasone—psoriasis	6.13e-05	0.000259	CcSEcCtD
Terbinafine—Diarrhoea—Dexamethasone—psoriasis	6.13e-05	0.000259	CcSEcCtD
Terbinafine—CYP19A1—Metabolism—CYP2S1—psoriasis	6.07e-05	0.00138	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—NDUFA5—psoriasis	6.01e-05	0.00137	CbGpPWpGaD
Terbinafine—Musculoskeletal discomfort—Methotrexate—psoriasis	5.94e-05	0.000251	CcSEcCtD
Terbinafine—Dizziness—Dexamethasone—psoriasis	5.93e-05	0.000251	CcSEcCtD
Terbinafine—Dizziness—Betamethasone—psoriasis	5.93e-05	0.000251	CcSEcCtD
Terbinafine—Nausea—Triamcinolone—psoriasis	5.87e-05	0.000248	CcSEcCtD
Terbinafine—Paraesthesia—Methotrexate—psoriasis	5.86e-05	0.000248	CcSEcCtD
Terbinafine—Hypersensitivity—Prednisone—psoriasis	5.75e-05	0.000243	CcSEcCtD
Terbinafine—Dyspepsia—Methotrexate—psoriasis	5.74e-05	0.000243	CcSEcCtD
Terbinafine—Vomiting—Dexamethasone—psoriasis	5.7e-05	0.000241	CcSEcCtD
Terbinafine—Vomiting—Betamethasone—psoriasis	5.7e-05	0.000241	CcSEcCtD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	5.68e-05	0.00129	CbGpPWpGaD
Terbinafine—Decreased appetite—Methotrexate—psoriasis	5.67e-05	0.00024	CcSEcCtD
Terbinafine—Rash—Betamethasone—psoriasis	5.65e-05	0.000239	CcSEcCtD
Terbinafine—Rash—Dexamethasone—psoriasis	5.65e-05	0.000239	CcSEcCtD
Terbinafine—Dermatitis—Dexamethasone—psoriasis	5.64e-05	0.000239	CcSEcCtD
Terbinafine—Dermatitis—Betamethasone—psoriasis	5.64e-05	0.000239	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Methotrexate—psoriasis	5.63e-05	0.000238	CcSEcCtD
Terbinafine—Fatigue—Methotrexate—psoriasis	5.62e-05	0.000238	CcSEcCtD
Terbinafine—Headache—Betamethasone—psoriasis	5.61e-05	0.000238	CcSEcCtD
Terbinafine—Headache—Dexamethasone—psoriasis	5.61e-05	0.000238	CcSEcCtD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.6e-05	0.00127	CbGpPWpGaD
Terbinafine—Asthenia—Prednisone—psoriasis	5.6e-05	0.000237	CcSEcCtD
Terbinafine—Pain—Methotrexate—psoriasis	5.58e-05	0.000236	CcSEcCtD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	5.56e-05	0.00126	CbGpPWpGaD
Terbinafine—Pruritus—Prednisone—psoriasis	5.52e-05	0.000234	CcSEcCtD
Terbinafine—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	5.51e-05	0.00125	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	5.47e-05	0.00124	CbGpPWpGaD
Terbinafine—Feeling abnormal—Methotrexate—psoriasis	5.37e-05	0.000227	CcSEcCtD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	5.35e-05	0.00122	CbGpPWpGaD
Terbinafine—Diarrhoea—Prednisone—psoriasis	5.34e-05	0.000226	CcSEcCtD
Terbinafine—Gastrointestinal pain—Methotrexate—psoriasis	5.33e-05	0.000226	CcSEcCtD
Terbinafine—Nausea—Betamethasone—psoriasis	5.32e-05	0.000225	CcSEcCtD
Terbinafine—Nausea—Dexamethasone—psoriasis	5.32e-05	0.000225	CcSEcCtD
Terbinafine—Urticaria—Methotrexate—psoriasis	5.18e-05	0.000219	CcSEcCtD
Terbinafine—Dizziness—Prednisone—psoriasis	5.16e-05	0.000218	CcSEcCtD
Terbinafine—Body temperature increased—Methotrexate—psoriasis	5.16e-05	0.000218	CcSEcCtD
Terbinafine—Abdominal pain—Methotrexate—psoriasis	5.16e-05	0.000218	CcSEcCtD
Terbinafine—PTGS1—Metabolism—CYP2S1—psoriasis	5.11e-05	0.00116	CbGpPWpGaD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	4.96e-05	0.00113	CbGpPWpGaD
Terbinafine—Vomiting—Prednisone—psoriasis	4.96e-05	0.00021	CcSEcCtD
Terbinafine—SQLE—Metabolism—APOE—psoriasis	4.95e-05	0.00112	CbGpPWpGaD
Terbinafine—Rash—Prednisone—psoriasis	4.92e-05	0.000208	CcSEcCtD
Terbinafine—Dermatitis—Prednisone—psoriasis	4.92e-05	0.000208	CcSEcCtD
Terbinafine—Headache—Prednisone—psoriasis	4.89e-05	0.000207	CcSEcCtD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.86e-05	0.0011	CbGpPWpGaD
Terbinafine—Hypersensitivity—Methotrexate—psoriasis	4.81e-05	0.000203	CcSEcCtD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.8e-05	0.00109	CbGpPWpGaD
Terbinafine—Asthenia—Methotrexate—psoriasis	4.68e-05	0.000198	CcSEcCtD
Terbinafine—Nausea—Prednisone—psoriasis	4.64e-05	0.000196	CcSEcCtD
Terbinafine—Pruritus—Methotrexate—psoriasis	4.61e-05	0.000195	CcSEcCtD
Terbinafine—CYP11A1—Metabolism—CARM1—psoriasis	4.48e-05	0.00102	CbGpPWpGaD
Terbinafine—Diarrhoea—Methotrexate—psoriasis	4.46e-05	0.000189	CcSEcCtD
Terbinafine—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	4.45e-05	0.00101	CbGpPWpGaD
Terbinafine—Dizziness—Methotrexate—psoriasis	4.31e-05	0.000182	CcSEcCtD
Terbinafine—SQLE—Metabolism—PPARG—psoriasis	4.31e-05	0.000979	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.18e-05	0.00095	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	4.16e-05	0.000946	CbGpPWpGaD
Terbinafine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	4.16e-05	0.000946	CbGpPWpGaD
Terbinafine—Vomiting—Methotrexate—psoriasis	4.15e-05	0.000175	CcSEcCtD
Terbinafine—Rash—Methotrexate—psoriasis	4.11e-05	0.000174	CcSEcCtD
Terbinafine—Dermatitis—Methotrexate—psoriasis	4.11e-05	0.000174	CcSEcCtD
Terbinafine—Headache—Methotrexate—psoriasis	4.09e-05	0.000173	CcSEcCtD
Terbinafine—CYP2C8—Metabolism—NDUFA5—psoriasis	3.88e-05	0.000882	CbGpPWpGaD
Terbinafine—Nausea—Methotrexate—psoriasis	3.87e-05	0.000164	CcSEcCtD
Terbinafine—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	3.75e-05	0.000852	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.62e-05	0.000822	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—NDUFA5—psoriasis	3.47e-05	0.000787	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CYP2S1—psoriasis	3.3e-05	0.00075	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.23e-05	0.000734	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—NDUFA5—psoriasis	3.19e-05	0.000724	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.18e-05	0.000723	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—NDUFA5—psoriasis	3.16e-05	0.000718	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CARM1—psoriasis	2.97e-05	0.000674	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CYP2S1—psoriasis	2.95e-05	0.000669	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.95e-05	0.000669	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.77e-05	0.00063	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—CAT—psoriasis	2.75e-05	0.000625	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CYP2S1—psoriasis	2.71e-05	0.000616	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—NDUFA5—psoriasis	2.7e-05	0.000613	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CYP2S1—psoriasis	2.69e-05	0.00061	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.68e-05	0.000608	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.52e-05	0.000572	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CARM1—psoriasis	2.5e-05	0.000567	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.33e-05	0.00053	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CYP2S1—psoriasis	2.3e-05	0.000522	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—APOE—psoriasis	2.14e-05	0.000486	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—NDUFA5—psoriasis	2.08e-05	0.000473	CbGpPWpGaD
Terbinafine—CYP11A1—Metabolism—PPARG—psoriasis	1.86e-05	0.000423	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—CAT—psoriasis	1.82e-05	0.000414	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.77e-05	0.000403	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.73e-05	0.000393	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CARM1—psoriasis	1.61e-05	0.000366	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.54e-05	0.000351	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—CAT—psoriasis	1.54e-05	0.000349	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.51e-05	0.000342	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CARM1—psoriasis	1.44e-05	0.000327	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—APOE—psoriasis	1.42e-05	0.000322	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.41e-05	0.00032	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.34e-05	0.000306	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CARM1—psoriasis	1.32e-05	0.000301	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CARM1—psoriasis	1.31e-05	0.000298	CbGpPWpGaD
Terbinafine—CYP19A1—Metabolism—PPARG—psoriasis	1.23e-05	0.00028	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.23e-05	0.000279	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.2e-05	0.000273	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—APOE—psoriasis	1.19e-05	0.000271	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CARM1—psoriasis	1.12e-05	0.000255	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.05e-05	0.000238	CbGpPWpGaD
Terbinafine—PTGS1—Metabolism—PPARG—psoriasis	1.04e-05	0.000236	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—CAT—psoriasis	9.92e-06	0.000225	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—CAT—psoriasis	8.85e-06	0.000201	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CARM1—psoriasis	8.65e-06	0.000197	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—CAT—psoriasis	8.14e-06	0.000185	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—CAT—psoriasis	8.07e-06	0.000183	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—APOE—psoriasis	7.7e-06	0.000175	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—CAT—psoriasis	6.9e-06	0.000157	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—APOE—psoriasis	6.88e-06	0.000156	CbGpPWpGaD
Terbinafine—CYP2C8—Metabolism—PPARG—psoriasis	6.71e-06	0.000152	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—APOE—psoriasis	6.32e-06	0.000144	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—APOE—psoriasis	6.27e-06	0.000142	CbGpPWpGaD
Terbinafine—CYP2C19—Metabolism—PPARG—psoriasis	5.99e-06	0.000136	CbGpPWpGaD
Terbinafine—CYP2D6—Metabolism—PPARG—psoriasis	5.51e-06	0.000125	CbGpPWpGaD
Terbinafine—CYP2C9—Metabolism—PPARG—psoriasis	5.46e-06	0.000124	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—APOE—psoriasis	5.36e-06	0.000122	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—CAT—psoriasis	5.32e-06	0.000121	CbGpPWpGaD
Terbinafine—CYP1A2—Metabolism—PPARG—psoriasis	4.67e-06	0.000106	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—APOE—psoriasis	4.14e-06	9.39e-05	CbGpPWpGaD
Terbinafine—CYP3A4—Metabolism—PPARG—psoriasis	3.6e-06	8.18e-05	CbGpPWpGaD
